<DOC>
	<DOCNO>NCT01648491</DOCNO>
	<brief_summary>Determine safety effectiveness technique use autologous stem cell treatment urinary incontinence one male subject .</brief_summary>
	<brief_title>Autologous Stem Cells Urinary Incontinence : Single Patient Compassionate Use</brief_title>
	<detailed_description>Autologous stem cell obtain subject needle biopsy , send lab multiplication 6 week time injected subject urethra .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>urinary incontinence fail urinary incontinence ( UI ) treatments meet inclusion criterion , gender age limit</criteria>
	<gender>Male</gender>
	<minimum_age>78 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>